SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-018193
Filing Date
2019-04-04
Accepted
2019-04-04 16:31:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv518210_sc13g.htm SC 13G 44079
  Complete submission text file 0001144204-19-018193.txt   45394
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Subject) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90530 | Film No.: 19732573
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Davidson Matt (Filed by) CIK: 0001741937 (see all company filings)

Type: SC 13G